2023
DOI: 10.3390/molecules28104210
|View full text |Cite
|
Sign up to set email alerts
|

Metal Complexes of Omadine (N-Hydroxypyridine-2-thione): Differences of Antioxidant and Pro-Oxidant Behavior in Light and Dark Conditions with Possible Toxicity Implications

Abstract: Omadine or N-hydroxypyridine-2-thione and its metal complexes are widely used in medicine and show bactericidal, fungicidal, anticancer, and photochemical activity. The redox activity of omadine complexes with iron, copper, and zinc on lipid peroxidation under light and dark conditions has been investigated. The monitoring of the oxidation of linoleic acid micelles, resembling a model of lipid membrane, was carried out using nuclear magnetic resonance (1H-NMR). It has been shown that the omadine–zinc complex c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 80 publications
(139 reference statements)
0
1
0
Order By: Relevance
“…Vitamin C has iron and other metal-binding capacities and is also a reducing agent, forming a complex with iron (III) followed by reduction to iron (II) [ 266 ]. The biological and clinical activities of iron, ascorbate, and the ascorbate–iron complex can also be affected by many other nutrients and pharmaceutical preparations, which may reduce or potentiate iron toxicity [ 274 , 275 , 276 , 277 , 278 ]. Similar effects to those shown in the interactions of vitamin C and iron are expected from other biomolecules with iron-chelating potential such as folic acid, lipoic acid, and catecholamines, as well as metal ions competing with iron [ 59 , 184 , 185 , 279 , 280 , 281 , 282 , 283 ].…”
Section: Iron Toxicity From Labile Forms Of Iron and Other Molecular ...mentioning
confidence: 99%
“…Vitamin C has iron and other metal-binding capacities and is also a reducing agent, forming a complex with iron (III) followed by reduction to iron (II) [ 266 ]. The biological and clinical activities of iron, ascorbate, and the ascorbate–iron complex can also be affected by many other nutrients and pharmaceutical preparations, which may reduce or potentiate iron toxicity [ 274 , 275 , 276 , 277 , 278 ]. Similar effects to those shown in the interactions of vitamin C and iron are expected from other biomolecules with iron-chelating potential such as folic acid, lipoic acid, and catecholamines, as well as metal ions competing with iron [ 59 , 184 , 185 , 279 , 280 , 281 , 282 , 283 ].…”
Section: Iron Toxicity From Labile Forms Of Iron and Other Molecular ...mentioning
confidence: 99%